AbbVie's Irish operations in firing line as Trump targets Botox prices
AbbVie, the company behind Botox, makes almost of all of the product in Westport, Co Mayo
Pharmaceutical giant AbbVie is one of the latest companies to be targeted by the US as the government plans to slash the price it pays for one of its key products, Botox, which is manufactured almost entirely in Ireland.
The US is planning to slash the price it pays for the cosmetic product along with several other medicines as part of legislation aiming to save the government over $200m (€168m).




